Health Condition 1: N915- Oligomenorrhea, unspecified
Conditions
Interventions
None listed
Sponsors
Dr Aishwarya Katara
Eligibility
Inclusion criteria
Inclusion criteria: Age group 18 to 40 years Interval between two menstrual cycles is greater than 35 days. Duration of menstrual flow is two days or less. Patients complaining of anartava, alpartava, and yonishool. Patients of primary, secondary amenorrhea and dysmenorrhea. PCOD with symptom of oligomenorrhea and hypomenorrhea.
Exclusion criteria
Exclusion criteria: Pregnant women, lactating mothers Positive to venereal diseases PCOD with menorrhagia Patients having any pelvic palpable pathology Any malignant growth Patient having congenital anomalies Patient having any known chronic systemic disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Decrease in interval between two menstrual cycle 2. Increase in amount of menstrual flow 3. Increase in time of menstrual period.Timepoint: 12 weeks The trial drug will be given for 3 months with anupana and follow up one month after cessation of medicine | — |
Secondary
| Measure | Time frame |
|---|---|
| State of PCOD,Hypomenorrhea, & Dysmenorrhea & also in artavakshaya.Timepoint: After analysing all parameters the result will be assessed on thon the basis of symptomatic relief & improvement Partially improvement after 4 wee patient gets 40-60 percent relief in sign & symptoms Improvement after 8 weeks patient gets 60-80 percent relief in sign & symptoms Cured after 12 weeks patient gets 80-100 percent relief in sign & symptoms | — |
Countries
India
Contacts
Public ContactDr Rama Khatavkar
Vaidya Yagyadutt Sharma Ayurveda Mahavidyalaya Khurja Uttar Pradesh
Outcome results
None listed